Mark Soden is a specialist with over 20 years’ executive search experience in the technology, media and telecoms (TMT) sector. He has an extensive global network and an impressive track record of C-level and board appointments for listed and privately owned businesses. One of his particular strengths is in building effective leadership teams for companies undergoing change and transformation.
The impact of ESG investing is too significant to ignore and with the battle for funds at its peak, the biotech industry needs to be at the forefront of the agenda. With impending mandates, the pressure is firmly on businesses to start thinking about their ESG proposition and how it may positively influence and affect the wider industry.